Ovarian Cancer Drugs Market Set to Reach USD 7.11 Billion by 2032 as Targeted Biologics, Novel ADCs, and Precision Oncology Reshape Therapeutic Paradigms According to an extensive industry evaluation published by Maximize Market Research, the global ovarian cancer drugs market is undergoing a structural transition from conventional cytotoxic chemotherapy toward highly targeted,...